Vistagen Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vistagen Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Vistagen Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.7M, a 20.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.7M -$451K -20.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.82M -$440K -19.5% Mar 31, 2024 10-Q 2024-08-13
Q4 2023 $1.93M -$431K -18.2% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $2.05M -$421K -17.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.15M -$411K -16% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.26M -$402K -15.1% Mar 31, 2023 10-K 2024-06-11
Q4 2022 $2.36M -$393K -14.2% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $2.47M -$563K -18.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.57M -$560K -17.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.66M -$558K -17.3% Mar 31, 2022 10-K 2023-06-28
Q4 2021 $2.76M -$555K -16.8% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $3.03M -$374K -11% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.13M -$367K -10.5% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.22M -$360K -10.1% Mar 31, 2021 10-K 2022-06-23
Q4 2020 $3.31M -$354K -9.64% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 $3.4M -$347K -9.26% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $3.49M -$341K -8.9% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $3.58M +$3.58M Mar 31, 2020 10-K 2021-06-29
Q4 2019 $3.67M Dec 31, 2019 10-Q 2020-02-13
Q3 2019 $3.75M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $3.83M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $0 Mar 31, 2019 10-K 2020-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.